Zevra Therapeutics Inc.
About
Zevra Therapeutics Inc. (NASDAQ:ZVRA) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 22 2026
Zevra Therapeutics Announces Details for Q1 2026 Financial Results Call
Mar 20 2026
Zevra Therapeutics Reports Inducement Grant to New Chief Financial Officer Under Nasdaq Listing Rule 5635(c)(4)
Mar 16 2026
Zevra Therapeutics Sells SDX Portfolio to Commave Therapeutics for $50 Million
Mar 10 2026
GeneDx to Launch Genetic Testing Program with Zevra Therapeutics to Support Patients with Suspected Niemann-Pick Disease Type C
Mar 9 2026
Zevra Reports Fourth Quarter and Full Year 2025 Financial Results
Financials
Revenue
$106.47 M
Market Cap
$551.89 M
P/E Ratio
6.96
EPS
1.35